The plasma concentrations of FVIII-RAg and
β-thromboglobulin (
β-TG) were measured in patients with collagen diseases (SLE; 32 cases, PSS; 20 cases) as well as in healthy controls (12 cases). The mean concentration of plasma FVIII-RAg in SLE was 193±94% (mean±SD), showing apparently elevated levels compared with healthy controls (P<0.05). There were no significant relations between the elevated levels of this antigen and abnormal data of ESR, CRP, complements and urinalysis. There were also no relations between plasma levels and clinical manifestations such as Raynaud’s phenomenon, livedo and acrocyanosis. Of the 32 SLE patients, however, 5 had clinical manifestations with acute, subacute or progressive blood vascular involvement; i. e., leukocyteclastic vasculitis, thrombophlebitis, livedo vasculitis, annular erythema, nodules with microthrombosis, and all these cases had plasma FVIII-RAg levels of more than 150%. We, therefore, concluded that increased FVIII-RAg levels can be an aid in confirming the acute or progressive phase of blood vascular damage in SLE patients. The mean concentration of plasma
β-TG in PSS patients (15 samples) was 240±89ng/ml (mean±SD), a significantly high level compared with the controls (6 samples, 120±23ng/ml) (P<0.01), suggesting positive platelet activation occurring in PSS patients.
View full abstract